Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Cash Flow Quality Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Cash Flow Quality Index of 13.56x as of June 2025. Operating cash flow of CN¥112.93 Million exceeds net income of CN¥8.33 Million, indicating high earnings quality where cash backs reported profits. Explore Shandong Jincheng Pharmaceutical and Che long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Quality Index (2008–2025)
Historical Cash Flow Quality Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300233 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year earnings quality comparison for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For live market cap and the full company financial profile, see Shandong Jincheng Pharmaceutical and Che (300233) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 7.23x | CN¥319.64 Million | CN¥44.19 Million | ▲ +406.7% |
| 2024 | 1.43x | CN¥296.59 Million | CN¥207.74 Million | ▼ -58.4% |
| 2023 | 3.44x | CN¥664.08 Million | CN¥193.31 Million | ▲ +284.2% |
| 2022 | 0.89x | CN¥255.63 Million | CN¥285.87 Million | ▼ -74.8% |
| 2021 | 3.55x | CN¥437.19 Million | CN¥123.08 Million | ▲ +31.5% |
| 2019 | 2.70x | CN¥577.98 Million | CN¥214.01 Million | ▲ +116.5% |
| 2018 | 1.25x | CN¥352.20 Million | CN¥282.31 Million | ▲ +138.5% |
| 2017 | 0.52x | CN¥151.83 Million | CN¥290.25 Million | ▼ -66.2% |
| 2016 | 1.55x | CN¥241.48 Million | CN¥156.25 Million | ▲ +25.8% |
| 2015 | 1.23x | CN¥207.92 Million | CN¥169.21 Million | ▼ -39.1% |
| 2014 | 2.02x | CN¥219.46 Million | CN¥108.70 Million | ▲ +38.9% |
| 2013 | 1.45x | CN¥93.92 Million | CN¥64.60 Million | ▼ -30.1% |
| 2012 | 2.08x | CN¥86.61 Million | CN¥41.61 Million | ▲ +85.9% |
| 2011 | 1.12x | CN¥62.69 Million | CN¥55.99 Million | ▲ +7.8% |
| 2010 | 1.04x | CN¥108.67 Million | CN¥104.62 Million | ▼ -19.7% |
| 2009 | 1.29x | CN¥105.62 Million | CN¥81.64 Million | ▲ +133.3% |
| 2008 | 0.55x | CN¥30.23 Million | CN¥54.52 Million | — |